Blood thinners prescribed after blood clots in leg or lung initially increase the risk of bleeding, especially in women and elderly.
FDA raises questions about Lilly’s Alzheimer’s drug; Adcomm votes against MDMA therapy; Inside Walmart Health’s challenges; and more
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
June 9, 2024